Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
life sciences
national blog main
boston blog main
boston top stories
fda
national top stories
san francisco blog main
clinical trials
san diego blog main
san diego top stories
san francisco top stories
boston
investing
ipo
seattle blog main
seattle top stories
startups
bio
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
deals
detroit blog main
detroit top stories
funding
indiana blog main
indiana top stories
medical device
medical devices
medicare
messenger rna
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
raleigh-durham blog main
raleigh-durham top stories
texas blog main
What
million
9
×
therapeutics
9
×
raised
ipo
company
new
cancer
developing
drug
public
treat
biotech
disorders
medical
sciences
shares
startup
week
went
according
adding
allogene
analytics
approach
athena
based
bets
betting
bio
biofourmis
biotechs
blackthorn
boost
brings
ceo
challenges
chief
clinical
club
companies
Language
unset
Current search:
biotech
×
million
×
therapeutics
×
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M